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The reactions of 1- or 2-naphthol, benzaldehyde or substituted benzaldehydes with tetrahy-
droisoquinoline, tetrahydrobenzo[d]azepine, tetrahydrobenzo[c]azepine or tetrahydrothieno[3,2-c]pyri-
dine under solvent-free conditions, allowed a series of tertiary aminonaphthols to be prepared. The
reactions were accelerated by the use of microwave irradiation, and the yields were also improved. As an
exception, the aminoalkylation of 2-naphthol with 1,2,3,4-tetrahydroisoquinoline in the presence of
benzaldehyde led to the parallel N-alkylation and redox a-arylation of the tetrahydroisoquinoline in
a ratio of 4:1. The reaction of 1-naphthol with 2,3,4,5-tetrahydro-1H-benzo[c]azepine led to the for-
mation of the N-alkylated compound as a single product, illustrating that the reaction route depends on
the structures of the cyclic amine and the naphthol.
 2015 Elsevier Ltd. All rights reserved.1. Introduction
The Mannich reaction1 is an important reaction involving CeC
bond formation that is widely used in the syntheses of secondary
and tertiary amine derivatives and as a key step in the syntheses of
many bioactive molecules and complex natural products.2 In the
pastdecade,modified three-componentMannich reactions (mMRs),
based on the aminoalkylation of 2- or 1-naphthol as electron-rich
aromatic compounds, have become of considerable importance for
the formation of aminonaphthols under mild experimental condi-
tions.3,4 The compounds obtained in thiswaydepend on the starting
nitrogen source: the use of primary or secondary amines leads to
secondary or tertiary aminonaphthols,5e10 while when ammonia is
used, primary aminonaphthols are obtained.11e15
In view of the two or more functional groups in the amino-
naphthols, one of the most important areas of application is the syn-
thesis of new heterocycles,3,4 while enantioenriched aminonaphthol
derivatives have been successfully applied in enantioselective trans-
formations.3,4 1-((2-Hydroxynaphthalen-1-yl)arylmethyl)piperidin-
4-ol derivatives were earlier designed and synthetized as novelmail address: fulop@pharm.selective ostrogen receptor modulators,16,17 while 1-[(6-halo- or
4-methylbenzo[d]thiazol-2-ylamino)phenylmethyl]naphthalen-2-ol
derivatives and 5-[(6-halo- or 4-methylbenzo[d]thiazol-2-ylamino)
phenylmethyl]quinolin-6-olderivativeswere foundtoexert repellent,
insecticidal and larvicidal activity against the mosquito Anopheles
arabiensis.18
The importance of the aminonaphthols prepared via mMRs has
recently increased because they have proved to be excellent model
compounds for study of the a-arylation/N-alkylation of cyclic
amines.19e21 When pyrrolidine was aminoalkylated with electron-
rich aromatic compounds in the presence of aromatic aldehydes,
the two possible main products, i.e. a-arylated orN-alkylated, could
be isolated only if the aldehyde component was added extremely
slow to the reaction mixture containing acid as catalyst. It was also
demonstrated that 2-naphthol can be sufficiently acidic to promote
the required tautomerization.20 This process, starting from 1,2,3,4-
tetrahydroisoquinoline as substrate, can theoretically lead to the
formation of the regioisomeric tertiary aminonaphthols (A or B)
according to Scheme 1, where HNu is an electron-rich aromatic
compound such as 2- or 1-naphthol. Our present primary aim was
to investigate the application of 1,2,3,4-tetrahydroisoquinoline and
analogous secondary amines such as 2,3,4,5-tetrahydro-1H-benzo
[c]azepine and 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in mMRs.
A further aim was a systematic investigation of the a-arylation/
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Scheme 1. Reaction pathway for the formation of the possible a-arylated (A) and N-alkylated (B) products starting from tetrahydroisoquinoline (1) (HNu¼nucleophile).
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hydrobenzazepine or tetrahydrothieno[3,2-c]pyridine by using 2-
or 1-naphthol as nucleophile in the presence of benzaldehyde.
2. Results and discussion
First, 1,2,3,4-tetrahydroisoquinoline (1), 2-naphthol (2) and
benzaldehyde were reacted under neat conditions at 65 C. After
a reaction time of 4 h, the desired 1-[(3,4-dihydro-1H-isoquinolin-
2-yl)phenylmethyl]naphthalen-2-ol (3, Scheme 2) was isolated by
crystallization with MeOH. Since the yield of the reaction was only
28%, the reaction was repeated under microwave (MW) irradiation
at 65 C. After a relatively long reaction time (1.5 h), the 1H NMR
spectra of the crude reaction mixture did not reveal the formation
of 3. The synthesis of 3 was earlier performed22 by refluxing 2,
1,2,3,4-tetrahydroisoquinoline (1) and benzaldehyde in ethanol for
12 h, 3 being isolated as a ‘yellow gummy solid’ in a yield of 78%.22
However when we attempted to repeat this under the same re-
action conditions, the 1H NMR spectra of the crude product in-
dicated that, the desired product 3 was formed in only trace
amounts.Scheme 2. Reaction of 1 with 2- or 1-naphthol in the presence of benzaldehyde.In the above experiments, the possibility of formation of the a-
arylated product 4 was not taken into account. For a systematic
investigation of this reaction, 4 was synthetized from 1-(1,2,3,4-
tetrahydroisoquinolin-1-yl)naphthalen-2-ol23 and benzyl bromide
on the basis of the literature process.24 2-Naphthol (2), 1,2,3,4-
tetrahydroisoquinoline (1) and benzaldehyde were reacted under
neat conditions at 65 C. The formation of the possible products (3
and 4) and the conversion of the reactionwere followed by 1H NMR
spectroscopy at different reaction times up to 10 h. The ratio of theproduct formed, 3:4, was found to be constant (4:1) throughout
reaction (Scheme 2).
To extend this mMR, 1-naphthol (5) was reacted with 1,2,3,4-
tetrahydroisoquinoline (1) in the presence of benzaldehyde, when
the possible products obtained by a-arylation/N-alkylation of 1
were 6 and 7 (Scheme 2). For a systematic study of this reaction, the
N-alkylated product 2-(2-benzyl-1,2,3,4-tetrahydroisoquinolin-
1-yl)naphthalen-1-ol (7) was synthetized from 2-(1,2,3,4-
tetrahydroisoquinolin-1-yl)naphthalen-1-ol23 and benzyl bro-
mide. 1-Naphthol (5), 1,2,3,4-tetrahydroisoquinoline (1) and benz-
aldehyde were reacted under neat conditions, by heating at 65 C,
or under MW irradiation at the same temperature. The presence of
the possible products (6 and 7) was followed by NMR spectroscopy,
with a comparison of the relative intensities of the characteristic
singlets of 6 and 7 in the crude product. Interestingly, in contrast
with our expectations, the signals of the crude product indicated
only the formation of 6when classical heating was applied at 65 C
(Scheme 2). This tendency seemed to be independent of the re-
action conditions (classical or MW heating): even after relatively
short reaction times (1.5 h on classical heating; 0.5 h on MW) both
conditions, led to the formation of 6 in excellent yields.The series of 2-substituted 1-naphthol analogs was extended
by using different 4-substituted benzaldehydes such as 4-
methoxybenzaldehyde or 4-chlorobenzaldehyde leading to, 8a and
8b (Scheme 3), while 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline
(9) was tested as substrate with 1-naphthol and benzaldehyde or
4-substituted benzaldehydes, leading to 10aec (Scheme 3).
To test the scope and limitations of the reaction, 1-naphthol was
reacted with other secondary cyclic amines, such as 2,3,4,5-
tetrahydro-1H-benzo[d]azepine (11), 2,3,4,5-tetrahydro-1H-benzo
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Scheme 3. Syntheses of tertiary aminonaphthols 8, 10, 12, 14 and 16 from 1-naphthol (reaction conditions and yields are listed in Table 1).
Table 1
Optimized reaction conditions for the syntheses of 6, 8, 10, 12, 14 and 16
Product Classical heating Yield (%) MW agitation Yield (%)
6 70 C, 12 h 58a 65 C, 0.5 h 78a
8a 70 C, 8 h 53a 65 C, 0.5 h 72a
8b 70 C, 5 h 57a 65 C, 0.5 h 74a
10a 70 C, 12 h 52b 65 C, 1 h 73b
10b 70 C, 7 h 60b 65 C, 0.5 h 77b
10c 70 C, 5 h 61b 65 C, 0.5 h 81b
12 60 C, 64 h 45c 55 C, 1.5 h 55c
14 60 C, 64 h 53c 55 C, 1.5 h 57c
16 65 C, 45 h 37d 60 C, 1,5 h 48d
a Recrystallized from iPr2O:MeOH (1:1).
b Recrystallized from MeOH.
c Recrystallized from iPr2O:MeOH (2:1).
d Recrystallized from iPr2O:MeOH (4:1).
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in the presence of benzaldehyde, leading to the formation of 12, 14
and 16. As concerns the aldehyde substrates, the highest yields were
obtained with 4-chlorobenzaldehyde, when shorter reaction times
too were needed (see the Experimental section). The yields of the
formationof 1-naphthol derivatives pointed to the lower reactivity of
4,5,6,7-tetrahydrothieno[3,2-c]pyridine (15) versus 1,2,3,4-
tetrahydroisoquinolines (1 and 9) or 2,3,4,5-tetrahydro-1H-benza-
zepines (11 and 13). When MW irradiation was applied the reaction
times were in all cases shorter, while the yields were improved.
Since the solvent-free heating of 1-naphthol with different cy-
clic amine substrates in the presence of the above aldehydes (either
by classical heating or by MWagitation) led to the formation of the
desired aminonaphthols (6, 8, 10, 12, 14 and 16) in good yields, our
attention turned back to the aminoalkylation of 2-naphthol. Thus,
tetrahydroisoquinoline (1) was reacted with 2-naphthol and 4-
methoxybenzaldehyde or 4-chlorobenzaldehyde under neat con-
ditions. The reaction was then extended by using different cyclic
amines, such as 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (9),
2,3,4,5-tetrahydro-1H-benzo[d]azepine (11), 2,3,4,5-tetrahydro-
1H-benzo[c]azepine (13) and 4,5,6,7-tetrahydrothieno[3,2-c]pyri-
dine (15). On the use of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (9), the aldehyde substrates were benzal-
dehyde, 4-methoxybenzaldehyde and 4-chlorobenzaldehyde. The
structures of the tertiary aminonaphthol products 17aeb, 18aec
and 19e21 are shown in Scheme 4.
When tetrahydroisoquinoline 1 was reacted with 2-naphthol in
the presence of 4-methoxybenzaldehyde or 4-chlorobenzaldehyde,
relatively long reaction times (classical heating: 20 h,MWagitation:
2.5 h) were needed. In all cases, the isolated yields were sufficiently
high to allow the conclusion that other a-arylated by-products were
absent. When 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (9)
was applied as starting material, a higher temperature (75 C) was
needed, a faster reaction as comparied with 3 and 17 can be as-
sumed. When 2,3,4,5-tetrahydro-1H-benzo[d]azepine (11), 2,3,4,5-
tetrahydro-1H-benzo[c]azepine (13) and 4,5,6,7-tetrahydrothieno
[3,2-c]pyridine (15) was used as cyclic amine, closely similar re-
action conditions were found to be optimum (Scheme 4).
A consideration of the yields of all the product aminonaphthols
(except 3 and 4) revealed the lowest yields for thosewhose synthesis
started from2,3,4,5-tetrahydro-1H-benzo[c]azepine (20). Thismight
be due to the lower stability of the benzazepine ring systemat higher
temperature, or to the formation of two regioisomers (N-alkylation
or a-substitution) during the reaction. To check on this, the syntheses
of 14 and 20 were repeated and the conversion of the starting
compounds was systematically followed via the NMR spectra of the
crude products. The desired aminonaphthols 14 and 20 were found
to be single products in the NMR spectra of the crude reaction mix-
tures, suggesting that the lower yields observed for 14 and 20 were
due to the lower stability of the starting benzazepine (13).3. Conclusions
Selective N-alkylations of tetrahydroisoquinolines, tetrahy-
drobenzo[d]azepine, tetrahydrobenzo[c]azepine and tetrahy-
drothieno[3,2-c]pyridine were achieved by using 1-naphthol and
aromatic aldehydes under neat conditions. The reactions were ex-
tended to 2-naphthol, and all were accelerated by using MW
agitation.
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Scheme 4. Syntheses of tertiary aminonaphthols 17e21 from 2-naphthol (reaction conditions and yields are listed in Table 2).
Table 2
Optimized reaction conditions for the syntheses of 3, 17e19, 20 and 21
Product Classical heating Yield (%) MW agitation Yield (%)
3 80 C, 4 h 46a 65 C, 1.5 h d
17a 70 C, 5 h 48c 65 C, 0.5 h 71c
17b 70 C, 5 h 50c 65 C, 0.5 h 77c
18a 75 C, 8 h 55b 70 C, 1 h 82b
18b 75 C, 8 h 57b 70 C, 1 h 84b
18c 75 C, 3.5 h 65b 70 C, 0.5 h 87b
19 60 C, 64 h 58a 60 C, 2 h 67a
20 60 C, 56 h 62d 60 C, 1.5 h 70d
21 75 C, 56 h 28a 70 C, 1.5 h 41a
a Recrystallized from iPr2O:MeOH (4:1).
b Recrystallized from MeOH.
c Recrystallized from iPr2O:MeOH (1:1).
d Recrystallized from iPr2O:MeOH (2:1).
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tetrahydroisoquinoline and benzaldehyde was reacted, MW heat-
ing did not lead to the formation of the desired aminonaphthol,
while classical heating resulted in two products: 1-[(3,4-dihydro-
1H-isoquinolin-2-yl)phenylmethyl]naphthalen-2-ol (3) and 1-(2-
benzyl-1,2,3,4-tetrahydroisoquinolin-1-yl)naphthalen-2-ol (4). The
ratio of 3:4was systematically studied at 65 C, and was found to be
4:1, independent of the reaction time. With 1-naphthol as nucleo-
phile in the aminoalkylation of 1 in the presence of benzaldehyde,
the N-alkylated compound 6was isolated as a single product. In the
reactions of 2,3,4,5-tetrahydro-1H-benzo[c]azepine, benzaldehyde
and 2- or 1-naphthol at 65 C, formation of the N-alkylated product
was assumed in each case. As a final conclusion for this three-
component mMR, a-arylation and N-alkylation are possible, but
the a-arylated productwas identified only in the case of the reaction
of 1,2,3,4-tetrahydroisoquinoline, 2-naphthol and benzaldehyde.
Which of the two possible products is formed therefore depends on
the structures of the cyclic amine and the nucleophilic partner
(2-naphthol or 1-naphthol).
4. Experimental
The 1H and 13C NMR spectrawere recorded in DMSO solutions in
5 mm tubes, at room temperature, on a Bruker spectrometer at 400
(1H) and 100.6 (13C) MHz, with the deuterium signal of the solvent
as the lock and TMS as internal standard. Melting points were de-
termined on a Hinotek X-4 melting point apparatus and areuncorrected. Elemental analyses were performed with a Per-
kineElmer 2400 CHNS elemental analyser. Merck Kieselgel 60F254
plates were used for TLC. The MW reactions were performed by
using a CEM Discover SP MW reactor.4.1. General method for the synthesis of 3, 6, 8, 10, 12, 14,
16e21
The reaction mixture of 0.5 mmol secondary amine (1, 9, 11, 13
or 15), 0.5 mmol aromatic aldehyde (benzaldehyde, 4-
chlorobenzaldehyde or 4-methoxybenzaldehyde) and 0.5 mmol
2- or 1-naphthol in a 10 mL pressurized reaction vial was heated in
an oil bath or in a CEM Discover SP MW reactor. After the reaction
times indicated in Tables 1 and 2, MeOH (5 mL) was added. The
crystals that separated out were filtered off and recrystallized.
4.1.1. 2-[(3,4-Dihydro-1H-isoquinolin-2-yl)phenylmethyl]naph-
thalen-1-ol (6). Mp: 138e140 C. 1H NMR: 2.80e2.96 (4H, m), 3.67
(1H, d, J¼15.1 Hz), 3.78 (1H, d, J¼15.1 Hz), 5.00 (1H, s), 6.94 (1H, d,
J¼7.4 Hz), 7.07e7.14 (1H, m), 7.14e7.19 (2H, m), 7.29 (3H, dd, J¼15.7,
8.6 Hz), 7.36 (2H, t, J¼7.5 Hz), 7.42e7.48 (2H, m), 7.58 (2H, d,
J¼7.7 Hz), 7.74e7.79 (1H, m), 8.12e8.17 (1H, m), 12.42 (1H, br s). 13C
NMR: 29.1, 49.2, 54.8, 74.0, 119.5, 120.3, 120.5, 122.8, 125.8, 126.7,
126.9, 127.4, 127.6, 127.8, 128.1, 128.6, 128.9 (2C), 129.3, 129.7 (2C),
134.1, 134.4, 139.0, 141.6, 152.0. IR: nmax 744, 753, 1387, 3031, 3737.
Anal. Calcd for C26H23NO: C, 85.45, H, 6.34, N, 3.83. Found: C, 85.47,
H, 6.35, N, 3.82.
4.1.2. 2-[(3,4-Dihydro-1H-isoquinolin-2-yl)-(4-methoxyphenyl)
methyl]naphthalen-1-ol (8a). Mp: 178e179 C. 1H NMR: 2.77e2.93
(4H, m), 3.64 (1H, d, J¼15.2), 3.70 (3H, s), 3.76 (2H, d, J¼15.2 Hz),
4.92 (1H, s), 6.90 (2H, d, J¼8.8 Hz), 6.97 (1H, d, J¼7.7 Hz), 7.05e7.11
(1H, m), 7.12e7.16 (2H, m), 7.23 (2H, dd, J¼29.9, 8.4 Hz), 7.39e7.47
(4H, m), 7.72e7.77 (1H, m), 8.08e8.14 (1H, m), 12.59 (1H, br s). 13C
NMR: 29.1, 49.1, 54.6, 55.9, 73.6, 115.1, 119.3, 120.4, 122.8, 125.7,
126.7, 126.9, 127.4, 127.6, 127.8, 128.1, 129.3, 130.2, 133.2, 134.0,
134.4, 134.5, 152.1, 159.6. IR: nmax 671, 1250, 1510, 2835, 3737. Anal.
Calcd for C27H25NO2: C, 82.00, H, 6.37, N, 3.54. Found: C, 82.01, H,
6.35, N, 3.56.
4.1.3. 2-[(4-Chlorophenyl)-(3,4-dihydro-1H-isoquinolin-2-yl)methyl]
naphthalen-1-ol (8b). Mp: 180e182 C. 1H NMR: 2.77e2.96 (4H, m),
J. Sas et al. / Tetrahedron 71 (2015) 7216e722172203.66 (1H, d, J¼15,2 Hz), 3.77 (1H, d, J¼15.2 Hz), 5.05 (1H, s),
6.97e7.02 (1H, m), 7.07e7.13 (1H, m), 7.15e7.19 (2H, m), 7.28 (1H, d,
J¼8.5 Hz), 7.33 (1H, d, J¼8.6), 7.40e7.49 (4H, m), 7.60 (2H, d,
J¼8.4 Hz), 7.75e7.80 (1H, m), 8.12e8.17 (1H, m), 12.18 (1H, br s). 13C
NMR: 29.1, 49.2, 54.7, 72.6, 119.7, 120.2, 122.5, 122.8, 125.7, 125.8,
126.7, 127.0, 127.4, 127.5, 127.6, 128.2, 129.3, 129.7, 130.7, 133.1, 134.1,
134.4, 140.7, 151.9. IR: nmax 671, 747, 1093, 1491, 2837, 3737. Anal.
Calcd for C26H22ClNO: C, 78.09, H, 5.54, N, 3.50. Found: C, 78.07, H,
5.56, N, 3.48.
4.1.4. 2-[(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)phenyl-
methyl]naphthalen-1-ol (10a). Mp: 164e166 C. 1H NMR:
2.76e2.88 (4H, m), 3.59 (1H, d, J¼15.3 Hz), 3.63 (3H, s), 3.71 (1H, d,
J¼15.3 Hz), 3.72 (3H, s), 4.96 (1H, s), 6.59 (1H, s), 6.73 (1H, s),
7.23e7.32 (3H, m), 7.36 (2H, t, J¼7.4 Hz), 7.42e7.48 (2H, m), 7.58
(2H, d, J¼7.5 Hz), 7.73e7.80 (1H, m), 8.12e8.18 (1H, m),12.61 (1H, br
s). 13C NMR: 28.7, 49.4, 54.5, 56.3, 56.4, 74.3,111.1, 112.6,119.4,120.3,
122.8, 125.7, 126.0, 126.1, 126.9, 127.8, 128.1, 128.6, 128.9 (2C), 129.7
(2C), 134.0, 141.6 (2C), 148.1, 148.4, 152.2. IR: nmax 698, 750, 1119,
1521, 2835, 3737. Anal. Calcd for C28H27NO3: C, 79.03, H, 6.40, N,
3.29. Found: C, 79.01, H, 6.42, N, 3.30.
4.1.5. 2-[(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-(4-
methoxyphenyl)methyl]naphthalen-1-ol (10b). Mp: 121e123 C. 1H
NMR: 2.75e2.88 (4H, m), 3.57 (1H, d, J¼14.4 Hz), 3.63 (3H, s),
3.66e3.72 (1H, m), 3.72 (6H, s), 4.90 (1H, s), 6.59 (1H, s), 6.73 (1H,
s), 7.20 (1H, d, J¼8.9 Hz), 7.28 (1H, d, J¼8.5 Hz), 7.41e7.49 (4H, m),
7.74e7.79 (1H, m), 8.11e8.17 (1H, m), 12.79 (1H, br s).13C NMR:28.8,
49.3, 54.3, 55.9, 56.3, 56.4, 73.8, 111.1, 112.6, 115.1 (2C), 119.2, 120.4,
122.8, 125.6, 125.7, 126.0, 126.2, 126.8, 127.9, 128.1, 130.2 (2C), 133.3,
134.0, 148.1, 148.4, 152.2, 159.6. IR: nmax 671, 808, 1122, 1257, 1508,
2935, 3734. Anal. Calcd for C29H29NO4: C, 76.46, H, 6.42, N, 3.07.
Found: C, 76.48, H, 6.41, N, 3.09.
4.1.6. 2-[(4-Chlorophenyl)-(6,7-dimethoxy-3,4-dihydro-1H-iso-
quinolin-2-yl)-methyl]-naphthalen-1-ol (10c). Mp: 132e133 C. 1H
NMR: 2.73e2.91 (4H, m), 3.58 (1H, d, J¼15.5 Hz), 3.64 (3H, s), 3.68
(1H, d, J¼15.5 Hz), 3.72 (3H, s), 5.01 (1H, s), 6.61 (1H, s), 6.73 (1H,
s), 7.29 (2H, dd, J¼22.0, 8.4 Hz), 7.39e7.49 (4H, m), 7.55e7.62 (2H,
m), 7.75e7.8 (1H, m), 12.32e12.47 (1H, br s). 13C NMR: 28.7, 49.5,
54.4, 56.3, 56.4, 73, 111.1, 112.6, 119.6, 120.1, 122.8, 125.8, 126.0,
126.1, 127.0, 127.6, 128.2, 129.2, 130.7, 133.1, 134.1, 140.7, 147.9,
148.1, 148.4, 152.0. IR: nmax 671, 1120, 1520, 3737. Anal. Calcd for
C28H26ClNO3: C, 73.11, H, 5.70, N, 3.05. Found: C, 73.13, H, 5.69, N,
3.07.
4.1.7. 2-[(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-phenyl-
methyl]-naphthalen-1-ol (12). Mp: 153e155 C. 1H NMR: 2.61e2.79
(4H, m), 2.93e3.00 (4H, m), 5.13 (1H, s), 7.06e7.10 (4H, m),
7.23e7.30 (2H, m), 7.32e7.38 (2H, m), 7.44e7.54 (5H, m), 7.74e7.79
(1H, m), 8.19e8.25 (1H, m), 13.12 (1H, br s). 13C NMR: 35.9 (2C),
53.6 (2C), 74.3, 118.9, 119.5, 122.9, 125.7, 126.1, 126.9, 127.2 (2C),
127.8, 128.1, 128.6, 129.5 (2C), 129.6 (2C), 129.7 (2C), 134.1, 140.0,
142.1 (2C), 152.9. IR: nmax 671, 748, 1387, 2833, 3737. Anal. Calcd for
C27H25NO: C, 85.45, H, 6.64, N, 3.69. Found: C, 85.46, H, 6.66, N,
3.70.
4.1.8. 2-[(4,5-Dihydro-1H-benzo[c]azepin-2(3H)-yl)phenylmethyl]
naphthalen-1-ol (14). Mp: 79e81 C. 1H NMR: 1.72 (2H, s),
2.71e2.79 (1H, m), 2.84e3.01 (3H, m), 3.87 (1H, d J¼14.0 Hz), 4.07
(1H, d, J¼14.0 Hz), 4.89 (1H, s), 6.48 (1H, d, J¼7.3 Hz), 7.00e7.11 (2H,
m), 7.17e7.28 (4H, m), 7.30e7.36 (2H, m), 7.41e7.47 (2H, m),
7.48e7.53 (2H, m), 7.72e7.78 (1H, m), 8.10e8.16 (1H, m), 12.46 (1H,
br s). 13C NMR: 26.8, 35.6, 56.9, 58.0, 71.6, 119.2, 120.3, 122.8, 124.1,
125.7, 126.7, 126.9, 127.7, 128.1 (2C), 128.5 (2C), 128.9 (2C), 129.6
(2C), 130.7, 134.0, 138.1, 141.7, 143.9, 152.4. IR: nmax 671, 744, 1390,1458, 2928, 3734. Anal. Calcd for C27H25NO: C, 85.45, H, 6.64, N,
3.69. Found: C, 85.43, H, 6.65, N, 3.71.
4.1.9. 2-[(6,7-Dihydro-4H-thieno[3,2-c]pyridin-5-yl)phenylmethyl]
naphthalen-1-ol (16). Mp: 161e162 C. 1H NMR: 2.88e2.99 (4H, m),
3.57 (1H, d, J¼14.7 Hz), 3.67 (1H, d, J¼14.7 Hz), 5.05 (1H, s),
6.75e6.78 (1H, m), 7.24e7.32 (4H, m), 7.33e7.38 (2H, m), 7.43e7.48
(2H, m), 7.57 (2H, d, J¼7.6 Hz), 7.75e7.79 (1H, m), 8.13e8.19 (1H,
m).13C NMR: 25.5, 49.5, 52.0, 73.4, 119.5, 120.4, 122.8, 123.1, 124.4,
125.8, 126.6, 126.9, 127.7, 128.1, 128.6, 128.9 (2C), 129.7 (2C), 133.5,
133.9, 134.0, 141.7, 152.0. IR: nmax 671, 698, 1506, 1558, 3737. Anal.
Calcd for C24H21NOS: C, 77.59, H, 5.70, N, 3.77. Found: C, 77.61, H,
5.68, N, 3.78.
4.1.10. 1-[(3,4-Dihydro-1H-isoquinolin-2-yl)phenylmethyl]naph-
thalen-2-ol (3). Mp: 151e152 C. 1H NMR: 2.74e3.02 (4H, m), 3.62
(1H, d, J¼14.6 Hz), 3.81 (1H, d, J¼14.6 Hz), 5.57 (1H, s), 6.96 (1H, d,
J¼7.4 Hz), 7.07e7.13 (2H, m) 7.14e7.19 (2H, m), 7.26 (2H, t, J¼7.4 Hz),
7.35 (2H, t, J¼7.5 Hz), 7.42 (2H, t, J¼7.5 Hz), 7.68e7.79 (4H, m), 8.13
(1H, d, J¼8.6 Hz), 13.27 (1H, br s). 13C NMR: 29.1, 49.5, 55.0, 70.2,
117.2, 120.5, 122.5, 123.4, 126.7, 127.3, 127.4, 127.6, 128.7, 129.1, 129.3
(2C), 129.4, 129.5, 129.7 (2C), 130.1, 132.8, 134.2, 134.3, 141.0, 155.7.
IR: nmax 739,1240,1452,1620, 2958, 3737. Anal. Calcd for C26H23NO:
C, 85.45, H, 6.34, N, 3.83. Found: C, 85.49, H, 6.37, N, 3.80.
4.1.11. 3,4-Dihydro-1H-isoquinolin-2-yl)-(4-methoxyphenyl)methyl]
naphthalen-2-ol (17a). Mp: 176e178 C. 1H NMR: 2.72e3.03 (4H,
m), 3.61 (1H, d, J¼15.4 Hz), 3.79 (1H, d, J¼15.4 Hz), 5.51 (1H, s), 6.90
(1H, d, J¼8.8 Hz), 6.98 (1H, d, J¼7.5 Hz), 7.06e7.13 (2H, m), 7.14e7.19
(2H, m), 7.26 (1H, t, J¼7.3 Hz), 7.41 (1H, t, J¼7.5 Hz), 7.6 (2H, d,
J¼8.4 Hz), 7.73 (1H, d, J¼8.9 Hz), 7.77 (1H, d, J¼7.8 Hz), 8.07 (1H, d,
J¼8.7), 13.38 (1H, br s). 13C NMR: 29.1, 49.4, 54.9, 55.9, 69.6, 115.1,
117.4, 120.5, 122.5, 123.3, 126.7, 127.3 (2C), 127.4, 127.6, 129.1, 129.3,
129.5, 130.0, 130.4, 130.6, 132.7, 132.8, 134.2, 134.3, 155.6, 159.6. IR:
nmax 757,1228,1512, 2958, 3737. IR: nmax 757,1228,1512, 2958, 3737.
Anal. Calcd for C27H25NO2: C, 82.00, H, 6.37, N, 3.54. Found: C, 82.07,
H, 6.42, N, 3.59.
4.1.12. 1-[(4-Chlorophenyl)-(3,4-dihydro-1H-isoquinolin-2-yl)
methyl]naphthalen-2-ol (17b). Mp: 180e181 C. 1H NMR: 2.72e3.00
(4H, m), 3.61 (1H, d, J¼15.3 Hz), 3.78 (1H, d, J¼15.3 Hz), 5.61 (1H, s),
6.98 (1H, d, J¼7.7 Hz), 7.06e7.12 (2H, m), 7.13e7.18 (2H, m), 7.26
(1H, t, J¼7.7 Hz), 7.37e7.45 (3H, m), 7.68e7.8 (4H, m), 8.12 (1H, d,
J¼8.2 Hz). 13C NMR: 29.1, 49.6, 54.9, 69.1, 116.9, 122.5, 123.5, 126.7,
127.4 (2C), 127.5, 127.6, 129.2, 129.3 (2C), 129.6, 129.7 (2C), 130.3,
131.2, 132.8, 133.3, 134.2, 134.3, 140.0, 155.6. IR: nmax 750, 833, 1071,
1492, 3737. Anal. Calcd for C26H22ClNO: C, 78.09, H, 5.54, N, 3.50.
Found: C, 78.12, H, 5.55, N, 3.52.
4.1.13. 1-[(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)phenyl-
methyl]naphthalen-2-ol (18a). Mp: 193e195 C. 1H NMR:
2.69e2.96 (4H, m), 3.53 (1H, d J¼15.3 Hz), 3.63 (3H, s), 3.70 (1H, d,
J¼14.9 Hz), 3.72 (3H, s), 5.54 (1H, s), 6.57 (1H, s), 6.72 (1H, s), 7.12
(1H, d, J¼8.8 Hz), 7.23e7.28 (2H, m), 7.34 (2H, t, J¼7.5 Hz), 7.42 (1H,
t, J¼7.8 Hz), 7.68e7.79 (4H, m), 8.12 (1H, d, J¼8.5 Hz), 13.42 (1H, br
s). 13C NMR: 28.8, 49.7, 54.7, 56.3, 56.4, 70.3,111.0, 112.5,117.3, 120.5,
122.4, 123.3, 125.9 (2C), 127.4, 128.7, 129.1, 129.4, 129.5 (2C), 129.7
(2C), 130.1, 132.9, 141.0, 148.1, 148.5, 155.7. IR: nmax 671, 742, 1521,
3737. Anal. Calcd for C28H27NO3: C, 79.03, H, 6.40, N, 3.29. Found: C,
79.08, H, 6.38, N, 3.26.
4.1.14. 1-[(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-(4-
methoxyphenyl)methyl]naphthalen-2-ol (18b). Mp: 207e209 C. 1H
NMR: 2.67e2.97 (4H, m), 3.52 (1H, d, J¼14.7 Hz), 3.64 (3H, s),
3.66e3.70 (1H, m), 3.7 (3H, s), 3.72 (3H, s), 5.48 (1H, s), 6.59 (1H, s),
6.72 (1H, s), 6.90 (2H, d, J¼8.3 Hz), 7.09 (1H, d, J¼8.8 Hz), 7.25 (1H, t,
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J¼8.8 Hz), 7.77 (1H, d, J¼7.9 Hz), 8.06 (1H, d, J¼8.4 Hz), 13.51 (1H, br
s). 13C NMR: 28.8, 40.4, 54.5, 55.9, 56.3, 56.4, 69.7, 111.0, 112.5, 115.0,
117.5, 120.5, 122.4, 123.3, 125.9, 126.0, 127.3, 129.1, 129.5, 129.9,
130.7, 132.7, 132.8, 148.1, 148.4, 155.7, 159.6. IR: nmax 671, 1510, 1521,
3737. Anal. Calcd for C29H29NO4: C, 76.46, H, 6.42, N, 3.07. Found: C,
76.43, H, 6.38, N, 3.12.
4.1.15. 1-[(4-Chlorophenyl)-(6,7-dimethoxy-3,4-dihydro-1H-iso-
quinolin-2-yl)-methyl]-naphthalen-2-ol (18c). Mp: 209e211 C. 1H
NMR: 2.67e3.01 (4H, m), 3.53 (1H, d, J¼15.0 Hz), 3.64 (3H,s),
3.65e3.71 (1H,m), 3.72 (3H, s), 5.59 (1H, s), 6.61 (1H, s), 6.72 (1H, s),
7.12 (1H, d, J¼8.8 Hz), 7.26 (1H, t, J¼7.5 Hz), 7.37e7.46 (3H, m),
7.68e7.81 (4H, m), 8.05e8.16 (1H, m), 13.32 (1H, br s). 13C NMR:
28.8, 49.8, 54.5, 56.3, 56.4, 69.3, 111.1, 112.5, 116.9, 120.5, 122.4,
123.4, 125.9 (2C), 127.5, 129.1, 129.6, 129.7 (2C), 130.3 (2C), 131.3,
132.8, 133.3, 140.0, 148.2, 148.5, 155.7. IR: nmax 671, 1124, 1523, 3587.
Anal. Calcd for C28H26ClNO3: C, 73.11, H, 5.70, N, 3.05. Found: C,
73.13, H, 5.71, N, 3.03.
4.1.16. 1-[(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)phenylmethyl]
naphthalen-2-ol (19). Mp: 201e203 C. 1H NMR: 1.59e1.85 (2H, m),
2.86e3.10 (4H, m), 3.87 (1H, d J¼14.7 Hz), 4.05 (1H, d J¼14.7 Hz),
5.45 (1H, s), 6.37 (1H, d, J¼7.5 Hz), 6.90e6.97 (1H, m), 7.07 (1H, d,
J¼8.7 Hz), 7.16e7.26 (4H, m), 7.27e7.38 (3H, m), 7.62 (2H, d,
J¼7.5 Hz), 7.73 (2H, dd, J¼15.4, 9.0 Hz), 7.81e7.89 (1H, m),13.26 (1H,
br s).13C NMR: 35.4, 40.6, 57.0, 58.1, 68.1, 120.4, 122.1, 123.2, 126.7,
127.2, 128.6 (2C), 129.0 (2C), 129.3 (2C), 129.5 (2C), 129.6, 130.1,
130.7, 132.6, 136.5, 141.4, 141.9, 143.9, 155.9. IR: nmax 752, 1267, 1452,
2935, 3435. Anal. Calcd for C27H25NO: C, 85.45, H, 6.64, N, 3.69.
Found: C, 85.48, H, 6.62, N, 3.72.
4.1.17. 1-[(4,5-Dihydro-1H-benzo[c]azepin-2(3H)-yl)phenylmethyl]
naphthalen-2-ol (20). Mp: 158e160 C. 1H NMR: 2.61e2.86 (4H, m),
2.88e3.03 (4H,m), 5.56 (1H, s), 7.07e7.15 (5H,m), 7.20e7.26 (2H,m),
7.31 (2H, t, J¼7.7Hz), 7.38 (1H, t, J¼7.5 Hz), 7.67 (2H, d, J¼7.5 Hz), 7.74
(2H, t, J¼9.7Hz), 8.04 (1H, d, J¼8.6Hz),13.75 (1H, br s).13CNMR: 35.3
(2C), 53.9 (2C), 69.9,117.7,120.6,122.3,123.2,127.2 (2C),127.3,128.6,
129.0,129.5 (2C),129.6 (2C),129.7 (2C),130.0,132.8,141.1,142.1 (2C),
142.2, 155.9. IR: nmax 740, 1236, 1624, 2827, 3737. Anal. Calcd for
C27H25NO: C, 85.45, H, 6.64, N, 3.69. Found: C, 85.43, H, 6.63, N, 3.70.
4.1.18. 1-[(6,7-Dihydro-4H-thieno[3,2-c]pyridin-5-yl)phenylmethyl]
naphthalen-2-ol (21). Mp: 142e143 C. 1H NMR: 2.79e3.09 (4H, m),
3.51 (1H, d, J¼14.4 Hz), 3.61e3.71 (1H, m), 5.62 (1H, s), 6.76 (1H, d,
J¼5.5), 7.11 (1H, d, J¼8.8 Hz), 7.22e7.28 (2H, m), 7.29e7.36 (3H, m),
7.42 (1H, t, J¼7.8 Hz), 7.67e7.8 (4H, m), 8.12 (1H, d, J¼8.5 Hz), 13.23
(1H, br s). 13C NMR: 25.5, 49.8, 52.2, 69.7, 117.3, 120.5, 122.5, 123.4,
124.6, 126.6, 127.4, 128.8, 129.1, 129.4, 129.5 (2C), 129.7 (2C), 130.1,
132.8,133.4,133.9,141.0,155.7. IR: nmax671,1558, 3734.Anal. Calcd for
C24H21NOS: C, 77.59, H, 5.70, N, 3.77. Found: C, 77.61, H, 5.68, N, 3.79.
4.2. Synthesis of 2-(2-benzyl-1,2,3,4-tetrahydroisoquinolin-1-
yl)naphthalen-1-ol (7)
A mixture of 2-(1,2,3,4-tetrahydroisoquinolin-1-yl)naphthalen-
1-ol25 (50 mg, 0.183 mmol), sodium carbonate (58 mg, 0.55 mmol)and benzyl bromide (40 mg, 0.23 mmol) was stirred in acetonitrile
(15 mL) in an oil bath at 70 C for 4 h. The solvent was then
evaporated off, 15 ml water was added to the residue and the so-
lution was extracted with DCM (310 mL). The combined organic
extracts were dried (Na2SO4) and concentrated in vacuum. The
residue was crystallized from iPr2O and recrystallized from n-
hexane:EtOAc (10 mL:1 mL).
Yield: 57 mg (85%), Mp: 148e149 C. 1H NMR: 2.54e2.61 (1H,
m), 2.81e2.89 (1H, m), 2.99e3.09 (1H, m), 3.17e3.24 (1H, m), 3.46
(1H,d, J¼13.4 Hz), 3.97 (1H,d, J¼13.4 Hz), 5.07 (1H, s), 6.87 (1H, d,
J¼8.0 Hz), 7.03 (1H, t, J¼7.7 Hz), 7.09e7.18 (2H, m), 7.28e7.33 (3H,
m), 7.35e7.41 (2H, m), 7.42e7.49 (3H, m), 7.50e7.54 (1H, m), 7.85
(1H, d J¼7.8 Hz), 8.11 (1H, d, J¼8.2 Hz). 13C NMR: 29.1, 47.7, 59.0, 67.1,
119.2,121.5, 122.7, 125.7, 125.8,126.7, 127.0, 127.1, 128.2, 128.3, 128.9,
129.2 (2C), 129.4 (2C), 130.1 (2C), 134.4, 134.7, 136.9, 137.7, 152.3. IR:
nmax 671, 1559, 3737. Anal. Calcd for C26H23NO: C, 85.45, H, 6.34, N,
3.83. Found: C, 85.47, H, 6.32, N, 3.81.Acknowledgements
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